Navigation Links
Program for young students increases interest in college attendance and medical careers
Date:11/16/2010

Two new studies have shown that a unique program in East Harlem that helps middle school students learn practical health skills and gain a better understanding of medical conditions, such as diabetes and hypertension, resulted in increased interest in college attendance and medical careers among the students who attended the program. The results were presented at the American Public Health Association (APHA) Annual Meeting this month in Denver.

The MedStart Summer Enrichment Program was created in the summer of 2009 by Edward Chu and Melissa Schneiderman, two third-year medical students at Mount Sinai School of Medicine. The free, one-week summer program is offered to East Harlem middle-school students who are interested in science and medicine, or who would benefit from a more interactive approach to learning. MedStart provides the participants with CPR and First Aid certification, and teaches them practical skills, such as how to take a pulse, and measure blood pressure. The program also provides transit passes, lunch, T-shirts, and trophies, at no cost to the students, for completing the program.

"East Harlem has one of the highest rates of asthma, diabetes, and obesity in all of New York City," said Chu. "We started the MedStart program because there was a significant unmet need for health care education among the youth of East Harlem about these diseases. A large number of medical students, residents, and faculty members were willing to dedicate time to help address this need, and MedStart was our solution."

The research team behind MedStart evaluated the impact of the program and presented the results at the APHA meeting. One study evaluated the impact of student attitudes toward science and medical careers before and after the program. Thirty-eight students completed the pre-program survey and 37 completed the post-survey. At the conclusion of the program, there was a 31 percent increase in students who were "very interested"
'/>"/>

Contact: Mount Sinai Press Office
newsmedia@mssm.edu
212-241-9200
The Mount Sinai Hospital / Mount Sinai School of Medicine
Source:Eurekalert

Page: 1 2

Related biology news :

1. Researchers develop new self-training gene prediction program for fungi
2. Childrens gardening programs grow environmental stewards
3. Color My Pyramid nutrition education program battles obesity in DC schools
4. Yamanaka eliminates viral vector in stem cell reprogramming
5. Salk researchers successfully reprogram keratinocytes attached to a single hair
6. Evolved Machines Selected as a Prime Contractor for DARPA Program to Engineer an Artificial Olfaction System
7. International Council for Science launches major research program on natural disasters
8. ICSU launches new program to understand the human impact on Earths life-support systems
9. SAIC Awarded $37 Million Contract to Support U.S. Army Program Executive Office - Enterprise Information Systems
10. TECNALIA leads five projects within the VII Framework Program
11. NWO and Academy launch research program with China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/9/2015)... , July 9, 2015  Unchained Labs ... announcing its acquisition of Avid Nano. Avid Nano ... scattering (DLS) systems.    Also today, ... fastest and easiest to use protein sizing system. ... measures a protein,s hydrodynamic size, size distribution, aggregation ...
(Date:7/8/2015)... July 8, 2015 Summary Pancreatic cancer ... fourth most fatal, with a mortality rate of 10.9 ... of pancreatic cancer patients has highlighted a significant need ... not being met by the current market. A ... products with varying molecule types and mechanisms of action, ...
(Date:7/8/2015)...  Trovagene, Inc. (NASDAQ: TROV ), a ... launch of a study that aims to determine ... technology for predicting response to treatment in advanced ... the novel immunotherapy agents Yervoy® (ipilumumab), a CTLA-4 ... 50-patient study will be led by researchers at ...
Breaking Biology News(10 mins):Unchained Labs just can't get enough, acquires Avid Nano, rocks out the new pUNk! 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 4
... This news release is available in French ... 2013 From office towers to shopping malls, educational institutions to ... all electricity consumed in Canada. Thanks to new research funding for ... and source of pollution. More than $2 million in funding ...
... in Florence last week. It provided us with some of the ... Did life begin on Mars rather than on earth?, Chelyabinsk meteor ... Bird", was probably a herbivore Goldschmidt2014 is due to ... so if you want to attend, put the dates in your ...
... planarian flatworms have the remarkable ability to regrow any missing ... study the molecular basis of regeneration. Over ... that differ depending on the severity of the injury they ... puncture wound reacts at the cellular and molecular levels quite ...
Cached Biology News:Buildings of the future 2Tissue loss triggers regeneration in planarian flatworms 2
(Date:7/30/2015)... , CA (PRWEB) , ... July 30, 2015 ... ... the successful completion of a field clinical study of its canine osteoarthritis stem ... together with Aratana Therapeutics (Kansas City, KS) and will be marketed in the ...
(Date:7/30/2015)... July 30, 2015 Ascendis Pharma A/S ... applies its innovative TransCon technology to address significant ... from a six-month Phase 2 study to evaluate ... Hormone in 53 treatment-naïve, pre-pubertal children with growth ... extremely pleased with the top-line results from our ...
(Date:7/30/2015)... ... 30, 2015 , ... GEA's Pony™ NS2006L is ... up to 1500 bar. The sanitary design gauge of the NS2006L is well ... The Pony™ NS2006L homogenizer is an ideal solution for the processing of ...
(Date:7/29/2015)... US-Australian drug discovery company, Novogen Limited (ASX: NRT; NASDAQ: ... progressing its ground-breaking technology platforms to Phase 1 clinical ... Company delivers the best value for shareholders. ... the Company currently had an extensive program of activities ... academic partnerships and initiatives, and he was working with ...
Breaking Biology Technology:VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 2VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 3Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 5Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 6Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 7GEA Announces the Pony™ NS2006L… a Self-contained, High Pressure Lab Homogenizer for Product Development Ensuring Maximum Efficiency and Safety 2Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 2Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 3Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 4Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 5Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 6Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 7Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 8Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 9Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 10
... /PRNewswire-FirstCall/ - Dragon Pharmaceutical Inc. ("Dragon Pharma" or the "Company" ... Special Meeting of Shareholders held today, its shareholders, including those ... Han, voted to approve the merger of Datong Investment Inc. ... Agreement and Plan of Merger dated March 26, 2010 ...
... ,, CAMPINA and PRAHOVA, Romania ... ( http://www.beikebiotech.com/index.php ), one of the,world,s leading biotechnology companies ... rehabilitation center to use traditional Chinese-style,rehabilitation techniques in Campina today. ... ...
... Volcano Corporation (Nasdaq: VOLC ), a leading developer and manufacturer of ... of coronary and peripheral vascular disease, today announced that it will report ... fiscal 2010 on Friday, July 30 . , ... The company will hold a conference call to ...
Cached Biology Technology:Dragon Pharma shareholders approve merger and seek termination of listing on the OTCBB and TSX 2Beike Biotechnology Opens First Chinese Rehabilitation Center in Romania 2Beike Biotechnology Opens First Chinese Rehabilitation Center in Romania 3Beike Biotechnology Opens First Chinese Rehabilitation Center in Romania 4Volcano Corporation Schedules Second Quarter Conference Call, Webcast 2